DE2043933C3 - N-(ß-Naphthylaminomethyl)-aminocarbonsäuren sowie diese enthaltende Arzneimittel - Google Patents

N-(ß-Naphthylaminomethyl)-aminocarbonsäuren sowie diese enthaltende Arzneimittel

Info

Publication number
DE2043933C3
DE2043933C3 DE2043933A DE2043933A DE2043933C3 DE 2043933 C3 DE2043933 C3 DE 2043933C3 DE 2043933 A DE2043933 A DE 2043933A DE 2043933 A DE2043933 A DE 2043933A DE 2043933 C3 DE2043933 C3 DE 2043933C3
Authority
DE
Germany
Prior art keywords
naphthylaminomethyl
compounds
mice
aminocarboxylic acids
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2043933A
Other languages
German (de)
English (en)
Other versions
DE2043933B2 (de
DE2043933A1 (de
Inventor
Saizo Kanao
Tadashi Kawasaki Suyama
Takeshi Sagamihara Toyoda
Shigeshi Toyoshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE2043933A1 publication Critical patent/DE2043933A1/de
Publication of DE2043933B2 publication Critical patent/DE2043933B2/de
Application granted granted Critical
Publication of DE2043933C3 publication Critical patent/DE2043933C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2043933A 1969-09-06 1970-09-04 N-(ß-Naphthylaminomethyl)-aminocarbonsäuren sowie diese enthaltende Arzneimittel Expired DE2043933C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7071669 1969-09-06

Publications (3)

Publication Number Publication Date
DE2043933A1 DE2043933A1 (de) 1971-03-11
DE2043933B2 DE2043933B2 (de) 1977-09-08
DE2043933C3 true DE2043933C3 (de) 1978-05-18

Family

ID=13439555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2043933A Expired DE2043933C3 (de) 1969-09-06 1970-09-04 N-(ß-Naphthylaminomethyl)-aminocarbonsäuren sowie diese enthaltende Arzneimittel

Country Status (5)

Country Link
US (1) US3801633A (OSRAM)
DE (1) DE2043933C3 (OSRAM)
FR (1) FR2070675B1 (OSRAM)
GB (1) GB1269908A (OSRAM)
NL (1) NL7013043A (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165258A (en) * 1975-10-08 1979-08-21 University Of Pennsylvania Plasminogen activating enzyme-specific competitive inhibitor
US4070478A (en) * 1977-02-17 1978-01-24 Merck & Co., Inc. Benzimidazole substituted alanines
FR2508444A1 (fr) * 1981-06-29 1982-12-31 Irceba Nouveaux derives sulfonyle du tryptophane utiles en tant que medicaments et leur procede de preparation
US5079260A (en) * 1989-06-22 1992-01-07 Nova Pharmaceutical Corporation Method for treating inflammation and compounds and compositions suitable for use therein
US5472973A (en) * 1991-12-12 1995-12-05 Scios Nova Inc. Fluorenyl derivatives as anti-inflammatory agents
IL104043A0 (en) * 1991-12-12 1993-05-13 Scios Nova Inc Fluorenyl derivatives and pharmaceutical compositions containing them
AU735013B2 (en) * 1996-09-04 2001-06-28 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
MD4110C1 (ro) * 2010-10-21 2011-12-31 Валериу РУДИК Preparat antiherpetiс
SG11201405413SA (en) 2012-03-30 2014-10-30 Givaudan Sa N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
BR112014023905B1 (pt) 2012-03-30 2021-07-13 Givaudan Sa Composições de sabor e comestíveis compreendendo derivados de metionina n-acilados e bebida calórica e não-calórica
CA2867329C (en) 2012-03-30 2020-03-10 Givaudan S.A. N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
CA2868073C (en) 2012-03-30 2020-12-29 Givaudan S.A. N-acyl proline derivatives as food flavouring compounds
KR102125587B1 (ko) 2012-03-30 2020-06-23 지보당 에스아 식품 향미 화합물인 n-아실-아미노산 유도체, 이를 함유하는 분말 조성물
EP2830440B1 (en) 2012-03-30 2019-03-20 Givaudan SA N-acyl-aminocyclopropyl carboxylic acids as food flavouring compounds
US10856563B2 (en) 2012-03-30 2020-12-08 Givaudan S.A. N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
EP3057448B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
CN105592720B (zh) 2013-10-02 2020-07-07 奇华顿股份有限公司 具有味道改进特性的有机化合物
US10834943B2 (en) 2013-10-02 2020-11-17 Givaudan S.A. Organic compounds having taste-modifying properties
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
CN105592719B (zh) * 2013-10-02 2020-03-10 奇华顿股份有限公司 有机化合物
CN105636934B (zh) 2013-10-02 2019-03-29 奇华顿股份有限公司 N-酰化的2-氨基异丁酸化合物和包含它们的香味组合物

Also Published As

Publication number Publication date
US3801633A (en) 1974-04-02
GB1269908A (en) 1972-04-06
DE2043933B2 (de) 1977-09-08
FR2070675B1 (OSRAM) 1974-09-27
DE2043933A1 (de) 1971-03-11
FR2070675A1 (OSRAM) 1971-09-17
NL7013043A (OSRAM) 1971-03-09

Similar Documents

Publication Publication Date Title
DE2043933C3 (de) N-(ß-Naphthylaminomethyl)-aminocarbonsäuren sowie diese enthaltende Arzneimittel
DE1768806C3 (de) Komplexe bzw. Salze aus einer antikoagulierend bzw. antilipämisch wirkenden sauren Heparinoidsäure-Komponente und einer nicht-toxischen Aminosäure bzw. organischen Base
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE2823346A1 (de) Antivirielles mittel und verfahren zur anwendung desselben bei virus-infektionen
DE1767163B2 (de) Pharmazeutisches Präparat
DE3730277C2 (de) Salz einer Organogermaniumverbindung und dessen Verwendung
DE2236876C3 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
DE3116211A1 (de) "nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel"
DE1768655A1 (de) Neue Salze der N-Carbamylglutaminsaeure und der N-Carbamylasparaginsaeure
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
DE1770697C3 (de) 2,2-(N-Methyl-2-azatetramethylen)- -adamantan, dessen Salze, Verfahren zu deren Herstellung und Arzneimittel
DE69118629T2 (de) Anti-AIDS-Zusammensetzung mit Cepharanthin als Wirkstoff
DE2416339C3 (de) Argininpyroglutaniat, Verfahren zu seiner Herstellung und Arzneimittel
DE3310584C2 (OSRAM)
DE2065966A1 (de) N-sulfonyl-aminocarbonsaeuren, sowie diese enthaltende arzneimittel
DE2615129C3 (de) Tripeptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2244737B2 (de) H-o-ChlorphenyD-2-tert-butylaminoäthanol, Verfahren zu dessen Herstellung und Arzneimittel auf dessen Basis
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink
DE1931927A1 (de) Neue Cyclohexylaminderivate
DE1693036B2 (de) Biguanide, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE1593970C3 (de) Homoargininpolymere und Verfahren zu ihrer Herstellung
DE1443386C3 (de) Verfahren zur Herstellung von 3-Cyanguanidinderivaten
AT338814B (de) Verfahren zur herstellung von neuen 4-(m-bromphenyl)-pyrazoldiazepin-verbindungen und von deren salzen
DE1951258A1 (de) Beta-Naphthylacetamidin und dessen Salze
DE1768376B2 (de) Aluminium - N-acetylglycinat und dieses als Wirkstoff enthaltende therapeutische Präparate

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
EHJ Ceased/non-payment of the annual fee